Pharmaceutical Excipients Market (2026 - 2035)
제약 부형제 시장 조사 보고서 - 2035년까지 예측
Forecast Period
2026-2035
CAGR
8.1%
2025 Market Size
USD 11.47 Billion
2035 Market Size
USD 24.88 Billion
Pharmaceutical Excipients Market 요약
Pharmaceutical Excipients Market 시장의 주요 기업은 다음과 같습니다
향후 전망
Pharmaceutical Excipients Market 향후 전망
보고서 범위
| Parameter | Detail |
| Market Scope | Global Pharmaceutical Excipients Market by product type, functionality, formulation, source and geography |
| Study Period | 2021–2035 (Historical 2021–2024; Base Year 2025; Forecast 2026–2035) |
| CAGR | 8.1% (2026–2035) |
| Market Size Checkpoints | USD 11.47 Billion (2025); USD 12.34 Billion (2026); USD 24.88 Billion (2035) |
| Fastest Growing Segments | Parenteral formulation; plant-based source; inorganic chemicals |
| Companies Profiled | 12 global and regional suppliers, including BASF, Roquette, Ashland, Evonik, Croda, DFE Pharma, JRS Pharma, Colorcon, Merck KGaA, Lubrizol |
| Valuation Currency | USD Billion |
시장 하이라이트
FAQs
How should procurement teams structure dual-sourcing in the Pharmaceutical Excipients Market without triggering costly requalification?
Qualify both sources concurrently during initial development, not after launch. Filing two suppliers in the original application avoids post-approval change submissions entirely and typically adds only 8–12 weeks to timelines [19].
What contractual protections matter most when signing a multi-year excipient supply agreement?
Prioritise change-notification clauses requiring 24-month advance notice of any manufacturing site, process or specification change. Add audit rights and guaranteed minimum inventory holdings at the supplier's site [11].
Do co-processed materials in the Pharmaceutical Excipients Market require separate regulatory review?
No independent approval exists, but co-processed blends need justification of functional performance and safety within the drug application. Compendial monographs now exist for several common combinations, which shortens the argument considerably [20].
How do inhalation-grade specifications differ from standard oral-grade materials?
Inhalation carriers require tightly controlled particle size distribution, fines content and surface energy — parameters irrelevant for tablets. Only a handful of sites globally hold qualification, which explains persistent supply tightness [28].
Which due-diligence signals distinguish reliable suppliers in the Pharmaceutical Excipients Market?
Look for IPEC-PQG GMP certification, Certificate of Suitability coverage, and a documented change-control history. Suppliers unable to produce three years of batch-level trend data on critical attributes should be treated cautiously [15].
Are novel excipients commercially viable given the absence of a standalone approval route?
Viability depends on partnering with a sponsor willing to carry the material through a first application. The FDA pilot programme reduces uncertainty but does not confer approval, so development costs remain sponsor-dependent [20].
How does nitrosamine risk assessment affect excipient selection today?
Secondary and tertiary amine content in materials now requires documented assessment, and some legacy grades have been reformulated. Buyers should request nitrosamine risk statements as a standard qualification document [15].
저자
Author
Rahul Gotadki
Co-Author
Nidhi Mandole
공유:
Secondary Research
The secondary research process involved comprehensive analysis of pharmacopeial databases, peer-reviewed pharmaceutical journals, chemical industry publications, and authoritative regulatory health organizations. Key sources included the US Food & Drug Administration (FDA), European Medicines Agency (EMA), International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), United States Pharmacopeia (USP), European Pharmacopoeia (EP), British Pharmacopoeia (BP), Japanese Pharmacopoeia (JP), World Health Organization (WHO) Prequalification Programme, International Pharmaceutical Excipients Council (IPEC) Americas, IPEC Europe, Japanese Pharmaceutical Excipients Council (JPEC), Chemical Abstracts Service (CAS), Pharmaceutical Research and Manufacturers of America (PhRMA), European Federation of Pharmaceutical Industries and Associations (EFPIA), National Institutes of Health (NIH) National Library of Medicine, National Center for Biotechnology Information (NCBI/PubMed), ScienceDirect, Google Scholar, US Census Bureau Economic Indicators, EU Eurostat Chemical Industry Database, and national pharmaceutical regulatory authority reports from key markets including China's National Medical Products Administration (NMPA) and India's Central Drugs Standard Control Organization (CDSCO). These sources were used to collect excipient usage statistics, regulatory monograph updates, DMF (Drug Master File) filing data, pharmaceutical production indices, clinical bioavailability studies, safety/toxicology profiles, and competitive landscape analysis for binders, diluents, disintegrants, lubricants, coating agents, and other functional excipient categories.
Primary Research
Qualitative and quantitative insights were obtained by interviewing supply-side and demand-side stakeholders during the primary research process. The supply-side sources consisted of Chief Executive Officers, Vice Presidents of Excipient Technology, Heads of Regulatory Affairs & Quality Assurance, Directors of Business Development, and Global Procurement Heads from excipient manufacturers, specialty chemical companies, and raw material suppliers. Demand-side sources included Chief Scientific Officers, Heads of Pharmaceutical Development, Formulation Scientists, Quality Control Directors, and Procurement Managers from innovator pharmaceutical companies, generic drug manufacturers, Contract Manufacturing Organizations (CMOs), Contract Development and Manufacturing Organizations (CDMOs), and research universities that were involved in drug delivery research. Primary research validated market segmentation across organic/inorganic excipient classifications, confirmed co-processing technology pipelines, and gathered insights on formulation adoption patterns, excipient premix strategies, and regulatory compliance dynamics including IPEC PQG GMP guidelines.
Primary Respondent Breakdown:
By Designation: C-level Primaries (30%), Director Level (32%), Others (38%)
By Region: North America (32%), Europe (30%), Asia-Pacific (28%), Rest of World (10%)
Market Size Estimation
Global market valuation was derived through revenue mapping and excipient consumption volume analysis. The methodology included:
Identification of 45+ key excipient manufacturers and suppliers across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa
Product mapping across binders, diluents, disintegrants, lubricants, coatings, colorants, flavors, and other functional excipient categories segmented by organic, inorganic, natural, and synthetic origins
Analysis of reported and modeled annual revenues specific to pharmaceutical excipient product lines for manufacturers including BASF SE, Dow Chemical Company, Evonik Industries AG, Ashland Global Holdings Inc., and Merck KGaA
Coverage of manufacturers representing 75-80% of global market share in 2024
Extrapolation using bottom-up (pharmaceutical production volume × excipient utilization rates by formulation type across solid, liquid, semi-solid, and novel drug delivery systems) and top-down (manufacturer revenue triangulation) approaches to derive segment-specific valuations and regional distribution metrics
공유:
무료 샘플 다운로드
이 보고서의 무료 샘플을 받으려면 아래 양식을 작성하십시오
공유:
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah Malgeri
Co-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph Aguayo
Sales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkamp
Account and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria Dodd
Program Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan Choi
Senior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Mark Irwin
Management Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif Moroglu
Strategy & Business Development Director
“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”
Guilherme Gomes Martins
Product Management Director
사례 연구
Aerospace & Defense
